Fierce Pharma Week 2025
Sep 10, 2025 | WednesdayPennsylvania, USA
Insights
In this insightful session at Fierce Pharma, discover practical strategies empowering Medical Science Liaisons (MSLs) to engage Key Opinion Leaders (KOLs) more effectively. This session delves into bridging the gap between access and meaningful impact, equipping MSLs with the tools and confidence to build credible, relevant scientific relationships that drive positive outcomes in pharmaceutical engagement. Watch the full video to learn how ProcDNA is revolutionizing MSL KOL interactions for greater impact and relevance.
Representative
Harpreet Singh
Co-founder, ProcDNA
Bryan Goldberg
Sr. Director, Strategy & Ops, Pharmacosmos
Key Takeaways from the Event
From Access to Impact
Shifting MSL engagement from merely accessing KOLs to creating meaningful, impactful scientific relationships that drive real world outcomes.
Building MSL Confidence and Credibility
Equipping MSLs with skills and strategies to engage KOLs confidently and establish themselves as trusted scientific partners.
Strategic KOL Prioritization
Identifying and focusing on KOLs who align closely with therapeutic goals and organizational priorities to maximize engagement relevance.
Data-Driven Personalization
Leveraging insights and digital tools to tailor interactions that resonate with individual KOLs’ interests and scientific priorities.
Trust through Transparent Dialogue
Establishing trust by maintaining transparent, evidence based, and ethically sound scientific communication with KOLs.
Measuring Engagement Success
Tracking engagement effectiveness by going beyond interaction counts to assess influence on decision making and outcomes.
Want to Gain Insights from the Event? Reach out to us
